Rxivist logo

Hispanic/Latino gastric adenocarcinoma patients have distinct molecular profiles including a high rate of germline CDH1 mutations

By Sam C. Wang, Yunku Yeu, Suntrea TG Hammer, Shu Xiao, Min Zhu, Changjin Hong, Lynn Y Yoon, Ibrahim Nassour, Jeanne Shen, Deepak Agarwal, Scott I Reznik, John C Mansour, Adam C Yopp, Hao Zhu, Tae Hyun Hwang, Matthew R Porembka

Posted 11 Sep 2019
bioRxiv DOI: 10.1101/764779 (published DOI: 10.1158/0008-5472.CAN-19-2918)

Hispanic/Latino patients have a higher incidence of gastric cancer and worse cancer-related outcomes as compared to patients of other backgrounds. Whether there is a molecular basis for these disparities is unknown, as very few Hispanic/Latino patients were included in previous studies. We performed a large, integrated genomic analysis of gastric cancer samples from Hispanic/Latino patients. Whole-exome sequencing (WES) and RNA sequencing were performed on 57 Hispanic/Latino gastric cancer patient samples. Germline analysis was conducted on 83 patients. Functional testing of CDH1 germline mutations was performed in Chinese hamster ovary cells. Tumors from Hispanic/Latino patients were significantly enriched for the genomically-stable subtype (as defined by The Cancer Genome Atlas), compared to Asians and Whites (65% vs 21% vs 20%, P < 0.001). Transcriptomic analysis identified molecular signatures that were prognostic. Of the 43 Hispanic/Latino patients with diffuse-type gastric cancer, 7 (16%) had germline mutations in CDH1 . Mutation carriers were significantly younger than non-carriers (41 vs 50 years, P < 0.05). E-cadherin expression was reduced in 5 of 6 mutation carrier tumor samples available for analysis. In silico algorithms predicted 5 variants were deleterious. For the two variants that were predicted to be benign, we demonstrated that the mutations conferred increased migratory capability, suggesting pathogenicity. Hispanic/Latino gastric cancer patients possess unique genomic landscapes. This includes a high rate of CDH1 germline mutations that may partially explain their aggressive clinical phenotypes. Individualized screening, genetic counseling, and treatment protocols based on patient ethnicity and race may be necessary.

Download data

  • Downloaded 396 times
  • Download rankings, all-time:
    • Site-wide: 96,180
    • In cancer biology: 2,868
  • Year to date:
    • Site-wide: None
  • Since beginning of last month:
    • Site-wide: 117,967

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide